Cannabis Science, a US-based biotech company that develops pharmaceutical cannabis products, has released the first Cannabis Science brand formulation. The new formulation contains oil in oral dispensing syringes for patient self-administration and is said to help patients use concentrated cannabis extracts to treat their ailments.
According to the company, it has received anecdotal reports of the successful cancer treatments with cannabis extracts. Cannabis Science has joined world authorities on phytocannabinoid science targeting critical illnesses, and adopts scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products.
via : PBR
You must be logged in to post a comment.